Xanomeline-Trospium (KarXT) Shows Efficacy in Phase 3 Trial for Schizophrenia

Поделиться
HTML-код
  • Опубликовано: 9 янв 2025

Комментарии • 13

  • @susansmith9462
    @susansmith9462 7 месяцев назад +5

    My 23 year old son experienced his first episode of psychosis and subsequent diagnosis of schizophrenia 18 months ago with 3 hospitalizations and is presently on 6mg daily of risperidone and 1mg of Rexulti. He is no longer hearing voices but the weight gain,lethargy, and cognitive changes are painful for me to watch. I have read a little about KarXT and felt optimistic but recently his young psychiatrist told us he attended a conference and there was lots of discussion of KarXT and the takeaway was that it only shows some benefit for first time psychosis patients never treated with other antipsychotics and only as an adjunct to other antipsychotics. Needless to say I am a little confused from that and hope he is mistaken because I was hoping that it is improved in September and we could gradually transition him to KarXT with a lower dose of risperidone

    • @constantinhaller4391
      @constantinhaller4391 6 месяцев назад

      Karxt can be tanken by itself and is very Strong on positiv Symptoms. We will See But it should be good.

    • @constantinhaller4391
      @constantinhaller4391 6 месяцев назад

      There is a german Company making a med called evenamide it can cure Patients coming out in 2026

  • @TheEclectic
    @TheEclectic 6 месяцев назад +2

    I can't wait to see this go up against risperidone, olanzapine, and olanzapine. As an inpatient psychiatrist, I probably won't be seeing this or using this with any of my patients any time soon, but hopefully its more effective than our current options and costs come down in the next few years!

  • @RynaxAlien
    @RynaxAlien 3 месяца назад +2

    When it will be available in EU?

  • @constantinhaller4391
    @constantinhaller4391 7 месяцев назад +5

    Its coming out end in september

  • @Pilkingmangleton
    @Pilkingmangleton 4 месяца назад +1

    Pills do not “treat” negative symptoms, there’s nothing to “lift”these are metabolic and mitocondrial dysfunction disorders of the brain and body. One new little drug that targets new mechanisms is a start but a pretty weak start. It is imperative that much better medications and brand new types of treatments are developed for all these people who have lost their lives and everything and everyone

    • @spiralinandspiralout
      @spiralinandspiralout 3 месяца назад

      Keto diet?

    • @Pilkingmangleton
      @Pilkingmangleton 3 месяца назад

      @@spiralinandspiralout people want mono therapies, keto diet is a fantastic thing to add to other metabolic interventions. Keto doesn’t work by itself…people want legitimate treatments that target the debth and breadth of negative symptoms in schizophrenia

  • @constantinhaller4391
    @constantinhaller4391 7 месяцев назад +2

    Better Wate for evenamide which can go into remission

  • @wolfram9579
    @wolfram9579 5 месяцев назад

    Will it, or will it not, affect dopamine and serotonin levels?

  • @therealhotchocolatecompany3962
    @therealhotchocolatecompany3962 5 месяцев назад +3

    If KarXT becomes available, will I be able to stop abilify and go on KarXT?

    • @Roberto11231
      @Roberto11231 5 месяцев назад +2

      If you have the money of course xD